STING1 and metabolic dysfunction-associated steatohepatitis: Therefore, it is important to further clarify the role of STING and its downstream signaling pathway in NAFL/NASH and to find inhibitors and agonists for the treatment of NAFLD and NASH-related HCC in the future.